Carlyle Group Inc. Portfolio Holdings

Carlyle Group Inc.

  • $80.8 Million
  • Q1 2025

Carlyle Group Inc. has filed its 13F form on May 09, 2025 for Q1 2025 where it was disclosed a total value porftolio of $80.8 Million distributed in 23 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Phathom Pharmaceuticals, Inc. with a value of $21.9M, Invitation Homes Inc. with a value of $16.6M, Vector Holding, LLC with a value of $10.8M, Cube Smart with a value of $9.42M, and Seacor Marine Holdings Inc. with a value of $6.86M.

Examining the 13F form we can see an decrease of $19.2M in the current position value, from $100M to 80.8M.

Carlyle Group Inc. is based out at Washington, DC

Below you can find more details about Carlyle Group Inc. portfolio as well as his latest detailed transactions.

Portfolio value $80.8 Million
Healthcare: $27.7 Million
Real Estate: $26.1 Million
Communication Services: $10.8 Million
Industrials: $9.01 Million
Consumer Cyclical: $4.89 Million
Consumer Defensive: $1.68 Million
Technology: $664,000

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$186M
$21.9 Million 27.15% of portfolio
3,496,808
Q2 2023 Added 19.14%
$20.6B
$16.6 Million 20.61% of portfolio
477,500
Q1 2023 New
$561M
$10.8 Million 13.36% of portfolio
6,234,252
Q1 2025 Reduced 28.21%
$9.8B
$9.42 Million 11.66% of portfolio
220,500
Q3 2022 New
$147M
$6.86 Million 8.5% of portfolio
1,355,761
Q4 2024 Added 1.81%
$282M
$4.89 Million 6.05% of portfolio
4,362,929
Q1 2025 Reduced 9.3%
$65.5M
$2.67 Million 3.3% of portfolio
1,838,486
Q1 2023 New
$30M
$2.24 Million 2.78% of portfolio
2,948,718
Q1 2024 Added 39.39%
$524M
$2.15 Million 2.67% of portfolio
107,214
Q3 2024 New
$501M
$1.68 Million 2.08% of portfolio
340,748
Q1 2024 New
$1.41M
$839,000 1.04% of portfolio
2,896,518
Q1 2023 New
$1.48B
$664,000 0.82% of portfolio
93,732
Q1 2024 New
Nucana PLC
-
$0 0.0% of portfolio
-
Q2 2024 New
Standardaero Inc
-
$0 0.0% of portfolio
-
Q1 2025 Added 1,912.52%
Complete Solaria Inc
-
$0 0.0% of portfolio
-
Q1 2025 Reduced 0.01%
Soleno Therapeutics Inc
-
$0 0.0% of portfolio
-
Q1 2025 Reduced 37.41%
Jasper Therapeutics Inc
-
$0 0.0% of portfolio
-
Q1 2024 New
Q32 Bio Inc
-
$0 0.0% of portfolio
-
Q1 2024 New
Pony Ai Inc
-
$0 0.0% of portfolio
-
Q4 2024 New
Maplebear Inc
-
$0 0.0% of portfolio
-
Q1 2025 Reduced 33.34%
Onkure Therapeutics Inc
-
$0 0.0% of portfolio
-
Q4 2024 New
Weride Inc
-
$0 0.0% of portfolio
-
Q4 2024 New

Summary

  • Portfolio
  • No. of Stocks 23
  • Current Value $80.8 Million
  • Prior Value $100 Million
  • Filing
  • Period Q1 2025
  • Filing Date May 09, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 0 stocks
  • Additional Purchases 1 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 5 stocks
Track This Portfolio

Track Carlyle Group Inc. Portfolio

Follow Carlyle Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Carlyle Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Carlyle Group Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email